Financial statements Drogomax
Balance sheet data of DROGOMAX
Year
|
2018
|
2019
|
2020
|
2021
|
---|---|---|---|---|
Total assets | 6 092 715,57 | 12 233 554,14 | 17 052 460,06 | 24 417 659,98 |
A. Fixed assets | 1 307 812,48 | 3 779 839,86 | 5 692 393,85 | 8 521 870,91 |
B. Current assets | 4 784 903,09 | 8 453 714,28 | 11 360 066,21 | 15 895 789,07 |
C. Share capital contributions (basic funds) | - | - | - | - |
D. Own shares (stocks) | - | - | - | - |
Total liabilities | 6 092 715,57 | 12 233 554,14 | 17 052 460,06 | 24 417 659,98 |
A. Equity | 746 904,05 | 3 914 977,66 | 6 364 715,25 | 8 556 588,63 |
B. Liabilities and provisions for liabilities | 5 345 811,52 | 8 318 576,48 | 10 687 744,81 | 15 861 071,35 |
I. Long-term liabilities | 1 115 613,02 | 1 989 642,71 | 2 665 505,78 | 3 220 815,61 |
II. Short-term liabilities | 4 218 067,21 | 6 314 027,80 | 7 357 184,72 | 11 637 837,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.